Insider · CIK 0001652827

Vasista Vittal

Reports to the SEC for 1 company · ROCKVILLE, MD

sec.gov

Transactions

Companies

Filings

CIK

0001652827

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-03-19	RGNXREGENXBIO Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+20K sh	$3.76	+$75.4K	246,534
2024-03-19	RGNXREGENXBIO Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−20K sh	—	—	0
2024-01-02	RGNXREGENXBIO Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−4,534 sh	$17.95	−$81.4K	210,467
2024-01-02	RGNXREGENXBIO Inc.A Award	Chief Financial Officer	AAward	+16K sh	—	—	226,493
2024-01-02	RGNXREGENXBIO Inc. · Stock Options (Right to buy)A Award	Chief Financial Officer	AAward	+76.3K sh	—	—	76,313
2023-05-31	RGNXREGENXBIO Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+35K sh	$0.85	+$29.8K	215,001
2023-05-31	RGNXREGENXBIO Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−35K sh	—	—	0
2023-01-03	RGNXREGENXBIO Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−1,333 sh	$22.68	−$30.2K	133,827
2023-01-03	RGNXREGENXBIO Inc.A Award	Chief Financial Officer	AAward	+46.2K sh	—	—	180,001
2023-01-03	RGNXREGENXBIO Inc. · Stock Options (Right to buy)A Award	Chief Financial Officer	AAward	+66.2K sh	—	—	66,233
2022-08-30	RGNXREGENXBIO Inc.S Sale	Chief Financial Officer	SSale	−2,400 sh	$30.24	−$72.6K	135,160
2022-08-05	RGNXREGENXBIO Inc.S Sale	Chief Financial Officer	SSale	−17.3K sh	$35.19	−$608K	137,560
2022-08-04	RGNXREGENXBIO Inc.S Sale	Chief Financial Officer	SSale	−400 sh	$35.00	−$14K	154,840
2022-08-01	RGNXREGENXBIO Inc.S Sale	Chief Financial Officer	SSale	−2,400 sh	$31.25	−$75K	155,240
2022-07-14	RGNXREGENXBIO Inc.S Sale	Chief Financial Officer	SSale	−468 sh	$30.00	−$14K	157,640
2022-07-13	RGNXREGENXBIO Inc.S Sale	Chief Financial Officer	SSale	−4,332 sh	$30.01	−$130K	158,108
2022-01-20	RGNXREGENXBIO Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+29.9K sh	$0.85	+$25.4K	162,440
2022-01-20	RGNXREGENXBIO Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−29.9K sh	—	—	35,000
2022-01-03	RGNXREGENXBIO Inc.A Award	Chief Financial Officer	AAward	+8,900 sh	—	—	132,540
2022-01-03	RGNXREGENXBIO Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+42.5K sh	—	—	42,500
2021-07-27	RGNXREGENXBIO Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+10K sh	$0.85	+$8,500	123,640
2021-07-27	RGNXREGENXBIO Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−10K sh	—	—	64,900
2021-01-15	RGNXREGENXBIO Inc.S Sale	Chief Financial Officer	SSale	−252 sh	$50.04	−$12.6K	113,640
2021-01-14	RGNXREGENXBIO Inc.S Sale	Chief Financial Officer	SSale	−11.1K sh	$50.03	−$555K	113,892
2021-01-12	RGNXREGENXBIO Inc.S Sale	Chief Financial Officer	SSale	−4,200 sh	$50.01	−$210K	124,985
2021-01-08	RGNXREGENXBIO Inc.S Sale	Chief Financial Officer	SSale	−2,460 sh	$46.45	−$114K	131,966
2021-01-08	RGNXREGENXBIO Inc.S Sale	Chief Financial Officer	SSale	−2,208 sh	$47.49	−$105K	129,758
2021-01-08	RGNXREGENXBIO Inc.S Sale	Chief Financial Officer	SSale	−573 sh	$48.15	−$27.6K	129,185
2021-01-07	RGNXREGENXBIO Inc.S Sale	Chief Financial Officer	SSale	−11K sh	$50.00	−$550K	134,426
2021-01-04	RGNXREGENXBIO Inc.A Award	Chief Financial Officer	AAward	+12.4K sh	—	—	145,424
2021-01-04	RGNXREGENXBIO Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+56.2K sh	—	—	56,200
2020-12-24	RGNXREGENXBIO Inc.S Sale	Chief Financial Officer	SSale	−3,376 sh	$50.00	−$169K	133,024
2020-12-23	RGNXREGENXBIO Inc.S Sale	Chief Financial Officer	SSale	−21.1K sh	$50.01	−$1.06M	136,400
2020-12-11	RGNXREGENXBIO Inc.S Sale	Chief Financial Officer	SSale	−14.9K sh	$40.17	−$599K	157,524
2020-12-10	RGNXREGENXBIO Inc.S Sale	Chief Financial Officer	SSale	−22.6K sh	$40.06	−$905K	172,440
2020-07-15	RGNXREGENXBIO Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+3,259 sh	$13.09	+$42.7K	209,974
2020-07-15	RGNXREGENXBIO Inc.S Sale	Chief Financial Officer	SSale	−15K sh	$40.10	−$599K	195,024
2020-07-15	RGNXREGENXBIO Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−3,259 sh	—	—	14,115
2020-05-11	RGNXREGENXBIO Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+500 sh	$13.09	+$6,545	207,215
2020-05-11	RGNXREGENXBIO Inc.S Sale	Chief Financial Officer	SSale	−500 sh	$40.00	−$20K	206,715
2020-05-11	RGNXREGENXBIO Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−500 sh	—	—	17,374
2020-05-08	RGNXREGENXBIO Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+2,500 sh	$13.09	+$32.7K	213,715
2020-05-08	RGNXREGENXBIO Inc.S Sale	Chief Financial Officer	SSale	−7,000 sh	$40.18	−$281K	206,715
2020-05-08	RGNXREGENXBIO Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−2,500 sh	—	—	17,874
2020-04-24	RGNXREGENXBIO Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+3,000 sh	$13.09	+$39.3K	223,215
2020-04-24	RGNXREGENXBIO Inc.S Sale	Chief Financial Officer	SSale	−12K sh	$40.11	−$481K	211,215
2020-04-24	RGNXREGENXBIO Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−3,000 sh	—	—	20,374
2020-04-23	RGNXREGENXBIO Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+3,000 sh	$13.09	+$39.3K	223,215
2020-04-23	RGNXREGENXBIO Inc.S Sale	Chief Financial Officer	SSale	−3,000 sh	$40.00	−$120K	220,215
2020-04-23	RGNXREGENXBIO Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−3,000 sh	—	—	23,374

Recent filings

Accepted (ET)
Mar 214
Vasista Vittal0001562180-24-002907
SEC(opens sec.gov)
Jan 44
Vasista Vittal0001562180-24-000246
SEC(opens sec.gov)
Jun 24
Vasista Vittal0001562180-23-004722
SEC(opens sec.gov)
Jan 54
Vasista Vittal0001562180-23-000224
SEC(opens sec.gov)
Aug 314
Vasista Vittal0001562180-22-006398
SEC(opens sec.gov)
Aug 84
Vasista Vittal0001562180-22-005938
SEC(opens sec.gov)
Aug 34
Vasista Vittal0001562180-22-005876
SEC(opens sec.gov)
Jul 154
Vasista Vittal0001562180-22-005681
SEC(opens sec.gov)
Jan 244
Vasista Vittal0001562180-22-000597
SEC(opens sec.gov)
Jan 44
Vasista Vittal0001562180-22-000170
SEC(opens sec.gov)

Companies

REGENXBIO Inc.Chief Financial OfficerRGNX

Address

C/O REGENXBIO INC. 9712 MEDICAL CENTER DRIVE, SUITE 100

ROCKVILLE, MD, 20850